Response to Lim et al. re: “Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19”

Q: What does this research mean for the field?

The authors provide clarifications and responses to questions raised regarding their prior study on the use of bone marrow mesenchymal stem cell-derived exosomes for treating severe COVID-19. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

Vikram Sengupta; Sascha Sengupta; Angel Lazo; Kevin C. Hicok; Timothy A. Moseley

doi:10.1089/scd.2020.0095

June 10, 2020Stem Cells and DevelopmentOpen Access

Response to Lim et al. re: “Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19”

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

Derived from Bone Marrow Mesenchymal Stem Cells asTreatment for Severe COVID-19'' [1] appreciate the questions that were submitted as a letter to the editor [2] and

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Sengupta et al. (2020) studied this question.

synapsesocial.com/papers/6aaa5dca337e25bc782ab21e https://doi.org/10.1089/scd.2020.0095

View Full Paper

Ask AI

Bookmark

Share

Response to Lim et al. re: “Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19”

Ask about this paper

Abstract

Discussion

Cite This Study

Response to Lim et al. re: “Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19”

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading